C-reactive protein is an independent predictor of mortality in women with HIV-1 infection

J Acquir Immune Defic Syndr. 2003 Feb 1;32(2):210-4. doi: 10.1097/00126334-200302010-00014.

Abstract

The relationship of C-reactive protein (CRP) to mortality was assessed in 209 HIV-1-infected women after adjusting for age, body mass index (BMI), serum albumin, CD4 cell lymphocyte count, and HIV-1 RNA. During the follow-up period of up to 5 years (median = 45 months) there were 49 deaths. CRP at study enrollment was measured using a low sensitivity assay. CRP levels were only weakly correlated (Pearson correlation coefficient r < .2) with other predictors of mortality. CRP was a powerful predictor of mortality (p < .01) after adjusting for age, BMI, serum albumin, CD4 cell lymphocytes, and HIV-1 RNA. The relative hazard associated with an elevated CRP level, independent of the covariates noted above, varied from 3.4- to 13.6-fold depending on how CRP values were grouped. CRP may be a useful and inexpensive predictor of HIV disease mortality in women.

Publication types

  • Comparative Study
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adult
  • Biomarkers / blood
  • C-Reactive Protein / analysis*
  • Cohort Studies
  • Female
  • HIV Infections / blood*
  • HIV Infections / mortality
  • HIV-1*
  • Humans
  • New York City / epidemiology
  • Prognosis
  • Proportional Hazards Models
  • Survival Analysis

Substances

  • Biomarkers
  • C-Reactive Protein